Latest filing published 05 Mar 2026 for 益丰药房, €72k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -34.3%Entry CN¥37.02 · Close at T+365 CN¥24.33
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
肖再祥: trading record in brief
肖再祥, listed as senior executive, appears in our data through filings on 益丰药房 shares, published by SSE / SZSE (CSRC). Over a trading history stretching from 11 December 2023 to 5 March 2026, the count stands at 3 filings.
On the open market, the record shows 1 purchase worth €11k and 2 sales worth €147k. The net balance comes to €136k on the selling side. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. So far in 2026, the count stands at no purchases and 2 sales.
The newest entry dates from 5 March 2026: an open-market sale of €72k, in 益丰药房. The most recent open-market purchase was published on 11 December 2023, 1,063 days ago. The median gap between trade and publication is zero days: most filings appear on the same day. This delay matters because a trade only becomes useful information once it is public. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 肖再祥
Open company profiles for insider transactions, fundamentals and analyst consensus when available.